These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34268565)

  • 21. Nursing Home Residents' Thoughts on Discussing Deprescribing of Preventive Medications.
    Thompson W; Jacobsen IT; Jarbøl DE; Haastrup P; Nielsen JB; Lundby C
    Drugs Aging; 2020 Mar; 37(3):187-192. PubMed ID: 31997117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment.
    Raghunandan R; Howard K; Ilomaki J; Hilmer SN; Gnjidic D; Bell JS
    Age Ageing; 2023 Aug; 52(8):. PubMed ID: 37596920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decisions on statin therapy by patients' opinions about survival gains: cross sectional survey of general practitioners.
    Halvorsen PA; Aasland OG; Kristiansen IS
    BMC Fam Pract; 2015 Jul; 16():79. PubMed ID: 26139240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice.
    Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J
    Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
    Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
    Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MediQuit - an electronic deprescribing tool: a pilot study in German primary care; GPs' and patients' perspectives.
    Michiels-Corsten M; Gerlach N; Junius-Walker U; Schleef T; Donner-Banzhoff N; Viniol A
    BMC Prim Care; 2022 Sep; 23(1):252. PubMed ID: 36162994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of GP perspectives on deprescribing antidepressants: a qualitative study.
    Kelly D; Graffi J; Noonan M; Green P; McFarland J; Hayes P; Glynn L
    BMJ Open; 2021 Apr; 11(4):e046054. PubMed ID: 33820792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General practitioners' preferences for future continuous professional development: evidence from a Danish discrete choice experiment.
    Kjaer NK; Halling A; Pedersen LB
    Educ Prim Care; 2015 Jan; 26(1):4-10. PubMed ID: 25654796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
    Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
    BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Communicating deprescribing decisions made in hospital with general practitioners in the community.
    Nguyen AD; Baysari MT; Duong M; Zheng WY; Ng B; Lo S; Robinson F; Hilmer SN
    Intern Med J; 2021 Sep; 51(9):1473-1478. PubMed ID: 33465266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying Use of a Health Virtual Community of Practice for General Practitioners' Continuing Professional Development: A Novel Methodology and Pilot Evaluation.
    Murad A; Hyde N; Chang S; Lederman R; Bosua R; Pirotta M; Audehm R; Yates CJ; Briggs AM; Gorelik A; Chiang C; Wark JD
    J Med Internet Res; 2019 Nov; 21(11):e14545. PubMed ID: 31774401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.
    Hamilton M; Mathieson S; Gnjidic D; Jansen J; Weir K; Shaheed CA; Blyth F; Lin CC
    Pain; 2022 Apr; 163(4):e518-e526. PubMed ID: 33990105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decision-Making Preferences and Deprescribing: Perspectives of Older Adults and Companions About Their Medicines.
    Weir K; Nickel B; Naganathan V; Bonner C; McCaffery K; Carter SM; McLachlan A; Jansen J
    J Gerontol B Psychol Sci Soc Sci; 2018 Sep; 73(7):e98-e107. PubMed ID: 29190369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.
    Schuling J; Gebben H; Veehof LJ; Haaijer-Ruskamp FM
    BMC Fam Pract; 2012 Jul; 13():56. PubMed ID: 22697490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
    Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
    BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.
    Turner JP; Edwards S; Stanners M; Shakib S; Bell JS
    BMJ Open; 2016 Mar; 6(3):e009781. PubMed ID: 26966056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
    Nilsson G; Samuelsson E; Söderström L; Mooe T
    BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice.
    Harmsen CG; Jarbøl DE; Nexøe J; Støvring H; Gyrd-Hansen D; Nielsen JB; Edwards A; Kristiansen IS
    BMC Health Serv Res; 2013 Feb; 13():76. PubMed ID: 23442351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deprescribing: Future directions for research.
    Thompson W; Reeve E; Moriarty F; Maclure M; Turner J; Steinman MA; Conklin J; Dolovich L; McCarthy L; Farrell B
    Res Social Adm Pharm; 2019 Jun; 15(6):801-805. PubMed ID: 30241876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.